ArticleAntimicrobial resistance and infection control2026
Evaluation of tuberculosis infection control measures in China's designated medical institutions: a comparative analysis of 2014 and 2022.
Article in Antimicrobial resistance and infection control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo assess the implementation of infection prevention and control (IPC) measures in municipal and higher-level tuberculosis (TB)-designated medical institutions and to identify areas for improvement by comparing data from 2014 and 2022.
methodsThis study compared infection control measures using data from 47 TB-designated medical institutions that participated in both the 2014 and 2022 national surveys. Implementation rates of administrative, environmental and respiratory protection measure were compared.
resultsA total of 47 institutions were analyzed, including 20 provincial institutions (42.6%) and 27 municipal institutions (57.4%). Overall infection control performance in 2022 was high and consistent across regions, levels, and grades. Significant improvements from 2014 to 2022 were observed in: dedicated pathways for patients/staff (80.9% vs. 97.9%, 17.0% increase), separate wards for smear-positive/smear-negative patients (63.8% vs. 87.2%, 23.4% increase), separate wards for drug-resistant/non-resistant patients (74.5% vs. 95.7%, 21.2% increase), and use of medical protective mask by staff (70.2% vs. 95.7%, 25.5% increase) (all P < 0.05). The use of air purification/filtration also increased significantly (14.9% vs. 57.4%, 42.5% increase, P < 0.001), with over 90% of institutions adopting natural ventilation and ultraviolet germicidal irradiation.
conclusionSignificant improvements in IPC measures were achieved between 2014 and 2022, particularly in administrative controls. However, further efforts are needed to standardize ward zoning management and ensure more equitable resource allocation across regions and institution levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.